Testing effectiveness (Phase 2)Study completedNCT00867607
What this trial is testing
Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis
Who this might be right for
Allergic Contact Dermatitis
Hadassah Medical Organization 13